Annual ROE
-858.96%
-763.08%-795.87%
December 31, 2023
Summary
- As of February 7, 2025, ASND annual return on equity is -858.96%, with the most recent change of -763.08% (-795.87%) on December 31, 2023.
- During the last 3 years, ASND annual ROE has fallen by -802.69% (-1426.50%).
- ASND annual ROE is now -730.61% below its all-time high of 136.21%, reached on December 31, 2012.
Performance
ASND ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
212.48%
-39.97%-15.83%
September 30, 2024
Summary
- As of February 7, 2025, ASND quarterly return on equity is 212.48%, with the most recent change of -39.97% (-15.83%) on September 30, 2024.
- Over the past year, ASND quarterly ROE has increased by +567.67% (+159.82%).
- ASND quarterly ROE is now -58.52% below its all-time high of 512.24%, reached on March 31, 2024.
Performance
ASND Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ASND ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -795.9% | +159.8% |
| 3 y3 years | -1426.5% | +531.8% |
| 5 y5 years | -1423.5% | +758.9% |
ASND ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1822.9% | at low | -58.5% | +124.1% |
| 5 y | 5-year | -1822.9% | at low | -58.5% | +124.1% |
| alltime | all time | -730.6% | at low | -58.5% | +124.1% |
Ascendis Pharma A/S ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 212.48%(-15.8%) |
| Jun 2024 | - | 252.45%(-50.7%) |
| Mar 2024 | - | 512.24%(-158.2%) |
| Dec 2023 | -858.96%(+795.9%) | -880.05%(+147.8%) |
| Sep 2023 | - | -355.19%(+80.9%) |
| Jun 2023 | - | -196.36%(+53.2%) |
| Mar 2023 | - | -128.14%(+30.8%) |
| Dec 2022 | -95.88%(+114.6%) | -97.95%(+50.3%) |
| Sep 2022 | - | -65.15%(+28.0%) |
| Jun 2022 | - | -50.89%(-8.5%) |
| Mar 2022 | - | -55.63%(+21.3%) |
| Dec 2021 | -44.67%(-20.6%) | -45.88%(-6.8%) |
| Sep 2021 | - | -49.21%(-19.8%) |
| Jun 2021 | - | -61.38%(+6.4%) |
| Mar 2021 | - | -57.69%(-5.3%) |
| Dec 2020 | -56.27%(+14.0%) | -60.92%(+9.6%) |
| Sep 2020 | - | -55.57%(+26.0%) |
| Jun 2020 | - | -44.12%(+24.5%) |
| Mar 2020 | - | -35.43%(-4.6%) |
| Dec 2019 | -49.35% | -37.14%(+15.2%) |
| Sep 2019 | - | -32.25%(-16.5%) |
| Jun 2019 | - | -38.60%(+7.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -35.81%(-20.4%) |
| Dec 2018 | -56.38%(-17.4%) | -45.01%(-7.1%) |
| Sep 2018 | - | -48.43%(-13.0%) |
| Jun 2018 | - | -55.67%(-18.8%) |
| Mar 2018 | - | -68.55%(-6.5%) |
| Dec 2017 | -68.23%(+43.2%) | -73.28%(+1.5%) |
| Sep 2017 | - | -72.17%(-0.3%) |
| Jun 2017 | - | -72.41%(+18.2%) |
| Mar 2017 | - | -61.26%(0.0%) |
| Dec 2016 | -47.65%(+22.1%) | -61.26%(-0.1%) |
| Sep 2016 | - | -61.34%(+35.1%) |
| Jun 2016 | - | -45.40%(+6.4%) |
| Mar 2016 | - | -42.66%(+52.7%) |
| Dec 2015 | -39.02%(-2.2%) | -27.93%(-1.1%) |
| Sep 2015 | - | -28.25%(-9.9%) |
| Jun 2015 | - | -31.37%(+75.4%) |
| Mar 2015 | - | -17.88%(-67.9%) |
| Dec 2014 | -39.88%(-139.6%) | -55.65%(+4.0%) |
| Sep 2014 | - | -53.50%(+743.8%) |
| Jun 2014 | - | -6.34%(-123.2%) |
| Mar 2014 | - | 27.36%(-22.4%) |
| Dec 2013 | 100.71%(-26.1%) | 35.27% |
| Dec 2012 | 136.21% | - |
FAQ
- What is Ascendis Pharma A/S annual return on equity?
- What is the all time high annual ROE for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual ROE year-on-year change?
- What is Ascendis Pharma A/S quarterly return on equity?
- What is the all time high quarterly ROE for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly ROE year-on-year change?
What is Ascendis Pharma A/S annual return on equity?
The current annual ROE of ASND is -858.96%
What is the all time high annual ROE for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual return on equity is 136.21%
What is Ascendis Pharma A/S annual ROE year-on-year change?
Over the past year, ASND annual return on equity has changed by -763.08% (-795.87%)
What is Ascendis Pharma A/S quarterly return on equity?
The current quarterly ROE of ASND is 212.48%
What is the all time high quarterly ROE for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly return on equity is 512.24%
What is Ascendis Pharma A/S quarterly ROE year-on-year change?
Over the past year, ASND quarterly return on equity has changed by +567.67% (+159.82%)